Manufacturer:

Bristol Myers Squibb

Name:

BREYANZI

Category:

Q Code

HCPCS:

Q2054

NDC(s):

73153-0900-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

BREYANZI is a Cancer drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The Q Code: Q2054 is aligned to the drug BREYANZI.